RE:RE:RE:RE:SO IM MISSING THE GOOD NEWS
Indeed...and one should not overlook the fact that there is a general doctor shortage, which is a growing & relatively hidden healthcare crisis. In the clinic, there are too many docs currently working under a major time crunch. Any protocol that requires fewer treatments will ultimately enable increased patient access & provide a doc more availability/time to treat another patient.
As people live longer, the number of specialty/cancer patients will grow & this will simply overextend an already stretched thin/tested healthcare system. Piling on ever-growing layers of bureaucracy/administrative-clerical tasks for docs creates an even bigger crisis.
Both docs and patients desperately want/need more efficient & simpler cost-effective options that aren't arriving soon enough. The FDA should be mindful of the many growing unmet needs...I'm betting my dollars to donuts on this one.